CD1A and breast carcinoma: We have previously shown that DCs are absent, or only present in very low numbers, in most human breast cancers using CD1a and other markers and that DCs are poorly activated (Coventry et al, 1997; Hillenbrand et al, 1999; Coventry et al, 2002).